GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannabis Strategic Ventures (OTCPK:NUGS) » Definitions » Cash Conversion Cycle

Cannabis Strategic Ventures (Cannabis Strategic Ventures) Cash Conversion Cycle : 93.78 (As of Jun. 2020)


View and export this data going back to 2005. Start your Free Trial

What is Cannabis Strategic Ventures Cash Conversion Cycle?

Cash Conversion Cycle is one of several measures of management effectiveness. It equals Days Sales Outstanding + Days Inventory - Days Payable.

Cannabis Strategic Ventures's Days Sales Outstanding for the three months ended in Jun. 2020 was 23.12.
Cannabis Strategic Ventures's Days Inventory for the three months ended in Jun. 2020 was 109.51.
Cannabis Strategic Ventures's Days Payable for the three months ended in Jun. 2020 was 38.85.
Therefore, Cannabis Strategic Ventures's Cash Conversion Cycle (CCC) for the three months ended in Jun. 2020 was 93.78.


Cannabis Strategic Ventures Cash Conversion Cycle Historical Data

The historical data trend for Cannabis Strategic Ventures's Cash Conversion Cycle can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannabis Strategic Ventures Cash Conversion Cycle Chart

Cannabis Strategic Ventures Annual Data
Trend Dec13 Dec14 Mar16 Mar17 Mar18 Mar19 Mar20
Cash Conversion Cycle
Get a 7-Day Free Trial - - 6,935.00 100.92 542.39

Cannabis Strategic Ventures Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Cash Conversion Cycle Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -29.47 -38.41 77.66 558.23 93.78

Competitive Comparison of Cannabis Strategic Ventures's Cash Conversion Cycle

For the Drug Manufacturers - Specialty & Generic subindustry, Cannabis Strategic Ventures's Cash Conversion Cycle, along with its competitors' market caps and Cash Conversion Cycle data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cannabis Strategic Ventures's Cash Conversion Cycle Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannabis Strategic Ventures's Cash Conversion Cycle distribution charts can be found below:

* The bar in red indicates where Cannabis Strategic Ventures's Cash Conversion Cycle falls into.



Cannabis Strategic Ventures Cash Conversion Cycle Calculation

Cash Conversion Cycle (CCC) measures how fast a company can convert cash on hand into even more cash on hand. This metric looks at the amount of time needed to sell inventory, the amount of time needed to collect receivables and the length of time the company is afforded to pay its bills without incurring penalties.

Cash Conversion Cycle is one of several measures of management effectiveness.

Cannabis Strategic Ventures's Cash Conversion Cycle for the fiscal year that ended in Mar. 2020 is calculated as

Cash Conversion Cycle=Days Sales Outstanding +Days Inventory-Days Payable
=85.27+578.01-120.89
=542.39

Cannabis Strategic Ventures's Cash Conversion Cycle for the quarter that ended in Jun. 2020 is calculated as:

Cash Conversion Cycle=Days Sales Outstanding+Days Inventory-Days Payable
=23.12+109.51-38.85
=93.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cannabis Strategic Ventures  (OTCPK:NUGS) Cash Conversion Cycle Explanation

Generally, the lower this number is, the better for the company. Although it should be combined with other metrics (such as ROE % and ROA %), it can be especially useful for comparing close competitors, because the company with the lowest CCC is often the one with better management.


Be Aware

CCC is most effective with retail-type companies, which have inventories that are sold to customers. Consulting businesses, software companies and insurance companies are all examples of companies for whom this metric is meaningless.

The CCC is one of several tools that can help you evaluate management, especially if it is calculated for several consecutive time periods and for several competitors. Decreasing or steady CCCs are good, while rising ones should motivate you to dig a bit deeper.


Cannabis Strategic Ventures Cash Conversion Cycle Related Terms

Thank you for viewing the detailed overview of Cannabis Strategic Ventures's Cash Conversion Cycle provided by GuruFocus.com. Please click on the following links to see related term pages.


Cannabis Strategic Ventures (Cannabis Strategic Ventures) Business Description

Traded in Other Exchanges
N/A
Address
9350 Wilshire Boulevard, Suite 203, Beverly Hills, CA, USA, 90212
Cannabis Strategic Ventures focuses on the medical and legal recreational cannabis sector. It provides temporary, permanent, and long-term staffing solutions, employment and human resources consulting to the legal Cannabis sector.
Executives
Gordon Samson director, officer: Chief Financial Officer 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Dane Brown director, officer: VP, Corporate Development 9595 WILSHIRE BOULEVARD, SUITE 900 BEVERLY HILLS CA 90212
Christopher G Foster director, officer: CFO, Secretary & Treasurer 5151 E. BROADWAY, SUITE 1600, TUCSON AZ 85711
Robert Hoegler director, 10 percent owner, officer: President #604 7040 GRANVILLE AVENUE RICHMOND A1 V6Y 3W5
Floyd Flaman director, 10 percent owner, officer: SECRETARY/TREASURER 5621 52ND STREET DELTA A1 V4K 2C7
Scott Marshall director, 10 percent owner, officer: President 2435 WEST 7TH AVENUE VANCOUVER A1 00000